文献速递主动脉疾病外周动脉疾病

Nellix系统治疗合并髂动脉瘤的腹主动脉瘤:单中心亚洲初期经验

Greater Compliance within Instruction for Use for Concomitant Iliac Aneurysms and Adverse Aneurysm Characteristics-Initial Experience with the Nellix Endovascular Aneurysm Sealing System at a Single Institution.
PubMed 文献 · Ann Vasc Surg · 2018-02-09

本研究回顾性分析15例亚洲男性肾下腹主动脉瘤合并髂动脉瘤患者,采用Nellix腔内动脉瘤封堵系统(EVAS)治疗。结果显示技术成功率100%,70%患者符合Nellix适应证,而标准EVAR适应证仅20%符合。早期结果提示EVAS在挑战性解剖中可行。

要点

  • Nellix EVAS技术成功率100%,70%患者符合其IFU,显著高于标准EVAR的20%。
  • 术后发现1例内漏(7%)和2例支架移位(14%),无动脉瘤或endobag破裂。

核心结论

  • Nellix EVAS在合并髂动脉瘤的腹主动脉瘤患者中早期结果良好,技术成功率高且并发症少。

研究设计与样本

  • 单中心回顾性研究,纳入2014年7月至2016年8月15例男性患者,由同一血管外科和介入放射团队行择期EVAS。

主要发现

  • 技术成功率为100%,70%患者符合Nellix IFU,而标准EVAR IFU仅20%符合。
  • 围术期并发症包括原有肾功能恶化6例、外周血管病3例、植入后综合征5例。
  • 术后检测到1例内漏(7%)和2例支架移位(14%),无动脉瘤或endobag破裂、肢体血栓形成或骨折。

临床怎么用

  • 对于合并髂动脉瘤、短颈或成角颈等挑战性解剖的腹主动脉瘤患者,Nellix EVAS可能提供更高的IFU符合率和良好的早期结果。

局限性

  • 样本量小(15例),单中心经验,随访时间短,需更大规模研究验证长期效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Nellix was introduced to Asia in 2014. Data in Asians have been sparse. Two balloon-expandable stents, each surrounded by a polymer-filled endobag, are deployed in parallel to obliterate and seal the aneurysm. This paradigm shift to treating abdominal aortic aneurysms confers advantages for certain adverse aneurysm morphology that is outside the instruction-for-use (IFU) for standard endovascular aneurysm repair (EVAR) devices. We examine outcomes of 15 Asian patients with concomitant infrarenal aortic and iliac artery aneurysms treated with the Nellix at our institution. METHOD: Between July 2014 and August 2016, 15 male patients underwent elective EVAS at a single tertiary center by the same team of vascular surgeons and interventional radiologists. Patient demographics, clinical presentations, aneurysm morphology, perioperative complications, and follow-up imaging according to the standardized protocol were studied. Preoperative CT images were analyzed using validated automatic 3-dimensional sizing software EndoSize. RESULT: The novel stent-graft deployment proves consistent and achieved a 100% technical success. Eleven patients (70%) complied within specified Nellix IFU, as compared to 20% if standard endovascular aneurysm repair (EVAR) IFU was applied. The difference is due to the presence of concurrent common iliac aneurysms (n = 5), short neck length (n = 3), and angulated necks (n = 3). Adjunct procedures included 3 open access endarterectomy with embolectomy, 1 coil embolization of internal iliac artery, 1 bilateral renal artery chimneys, and 1 proximal stent deployment. There was no conversion to open surgery. Average operative time was 133 min. Median length of stay was 4 days. Thirty-day mortality was 0%. Perioperative morbidity included exacerbation of pre-existing renal impairment (n = 6), peripheral vascular disease (n = 3), and postimplantation syndrome (n = 5). One endoleak (7%) and 2 instances of stent migration (14%) were detected. There was no complication of aneurysm or endobag rupture, limb thromboses, or fracture. CONCLUSIONS: Early data in our center are encouraging and highlight high procedural success with minimal complications despite challenging patient anatomy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jeffrey Hing JX, Ch'ng JK, Tay KH, et al. Greater Compliance within Instruction for Use for Concomitant Iliac Aneurysms and Adverse Aneurysm Characteristics-Initial Experience with the Nellix Endovascular Aneurysm Sealing System at a Single Institution. Ann Vasc Surg. 2018. PMID: 29428533. doi:10.1016/j.avsg.2018.01.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。